BFA
ARCT icon

BlackRock Fund Advisors’s Arcturus Therapeutics ARCT Stock Holding History

BlackRock Fund Advisors’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-55,195
Closed -$954K – 4241
2016
Q3 		$954K Buy
55,195
+3,605
+7% +$116K ﹤0.01% 3229
2016
Q2 		$1.62M Buy
51,590
+931
+2% +$29.3K ﹤0.01% 3221
2016
Q1 		$1.34M Buy
50,659
+5,174
+11% +$175K ﹤0.01% 3157
2015
Q4 		$2M Buy
+45,485
New +$2.05M ﹤0.01% 3151

Other funds holding ARCT

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

BlackRock Fund Advisors's ARCT Position: Q4 2016 in Review

BlackRock Fund Advisors sold out of Arcturus Therapeutics (ARCT) in Q4 2016, closing a stake of 55,195 shares — an estimated $954K sold.

BlackRock Fund Advisors first reported a position in ARCT in Q4 2015 and held it in 4 quarters. The position peaked at $2M in Q4 2015. 42 funds tracked by Wall St. Rank hold ARCT as of Q4 2016.

  • BlackRock Fund Advisors reported no remaining Arcturus Therapeutics position as of Q4 2016 after selling out during the quarter.
  • BlackRock Fund Advisors sold 55,195 Arcturus Therapeutics shares in Q4 2016, an estimated $954K.
  • BlackRock Fund Advisors first reported a position in Arcturus Therapeutics in Q4 2015 and held it in 4 quarters.
  • BlackRock Fund Advisors's Arcturus Therapeutics position peaked at $2M in Q4 2015.
  • 42 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.